Recombinant Human DTWD1 Protein，His

DTWD1 (Dihydroorotate Dehydrogenase 1) is an enzyme that plays a crucial role in the de novo pyrimidine biosynthesis pathway, responsible for the conversion of dihydroorotate to orotate, a key precursor for nucleotide synthesis. Understanding the structure and function of DTWD1 is critical due to its implications in various biological processes, including cell proliferation and differentiation. Dysregulation of pyrimidine metabolism has been linked to several diseases, including cancer and autoimmune disorders. As a result, DTWD1 is emerging as a potential therapeutic target for developing innovative treatments. The reconstitution of DTWD1 as a recombinant protein provides an essential tool for detailed biochemical studies, allowing researchers to analyze its enzymatic activity, substrate specificity, and inhibition by potential drug candidates. Furthermore, studying the protein's structure through techniques like X-ray crystallography or NMR can reveal insights into the molecular mechanisms underlying its function and interactions with other biomolecules. This research not only enhances our understanding of DTWD1's biological role but also paves the way for exploring its potential as a drug target, ultimately contributing to the development of novel therapeutic strategies.